Altor BioScience gets rights to T-cell receptor technology

09/11/2008 | American City Business Journals

Altor BioScience has secured exclusive worldwide rights to develop Massachusetts General Hospital's T-cell receptor technology for use in the treatment of HIV and hepatitis C. New medicines are needed as AIDS and HIV patients continue to develop resistance to existing anti-retroviral drugs, Altor said.

View Full Article in:

American City Business Journals

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice-President of Technology and Regulatory Affairs
AdvaMed
Washington DC, DC
Sr Product Manager Global Marketing (US/DA/00/0085/SL) - 14000009V3
Abbott
Chicago, IL
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Vice President, Information Technology
HealthPartners
MN